Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2024-02-19 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
股东大会议事规则
Governance Information Classification · 100% confidence The document is titled as the "Shareholders' Meeting Rules" of Zhejiang Tailin Biotechnology Co., Ltd. It extensively details the procedures, rules, and regulations governing the conduct of shareholders' meetings, including the convening, proposal submission, voting, and other operational aspects of such meetings. There is no indication that this is a report of an actual meeting, nor is it a notice or announcement of a meeting or voting results. Instead, it is a governance document outlining internal rules and procedures related to shareholder meetings and corporate governance. This aligns with the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length (9445 characters) and content confirm it is not a brief announcement or a transcript but a detailed governance document.
2024-02-19 Chinese
独立董事专门会议工作制度
Governance Information Classification · 95% confidence The document is a detailed internal governance policy titled 'Independent Directors Special Meeting Work System' for Zhejiang Tailin Biotechnology Co., Ltd. It outlines the roles, responsibilities, meeting procedures, and powers of independent directors in the company. The content focuses on governance structure and internal rules rather than financial data, audit results, or shareholder voting outcomes. It does not contain financial statements, audit opinions, or announcements of voting results. It is a governance-related document describing board practices and procedures, fitting the definition of Governance Information (CGR). The document length is 1808 characters, which is relatively short but contains substantive governance content, not just an announcement or notice. Therefore, the appropriate classification is CGR with high confidence.
2024-02-19 Chinese
重大资产管理制度
Governance Information Classification · 95% confidence The document is titled '重大资产管理制度' which translates to 'Major Asset Management System' and outlines the governance structure and procedures related to major financial decisions such as bank loans, asset sales, asset pledges, and organizational adjustments. It references company laws and the company's articles of association, indicating it is a governance-related internal policy document. There is no indication of financial statements, audit results, or regulatory filings. The content focuses on internal governance rules and procedures for managing significant assets and decision-making authority within the company. Therefore, this document fits best under Governance Information (CGR). The document length is short and it is not an announcement or a report publication, so it is not RPA or RNS.
2024-02-19 Chinese
独立董事工作制度
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the rules, responsibilities, nomination, election, and duties of independent directors within the company. It references company law, stock exchange rules, and governance practices. The content is focused on governance structure and internal rules related to board members, specifically independent directors. There is no financial data, earnings information, or report publication mentioned. The document is a governance-related policy document rather than a report or announcement. Therefore, it fits best under Governance Information (CGR). The document length (8194 characters) supports it being a full policy document rather than a brief announcement.
2024-02-19 Chinese
关于董事会提议向下修正泰林转债转股价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding a proposal by the board of directors to downward adjust the conversion price of its convertible bonds ("Tailin Convertible Bonds"). It details the background of the bonds, previous adjustments to the conversion price, the conditions triggering the current proposed adjustment, and the procedural requirements including shareholder approval. The document is a formal disclosure about a capital structure change related to convertible bonds, specifically focusing on the adjustment of the conversion price. It does not contain financial statements or comprehensive financial performance data, nor is it a report or presentation. It is an update on a financing-related matter, specifically a capital/financing update about convertible bond terms. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 3121 characters, which is consistent with an announcement rather than a full report.
2024-02-19 Chinese
内部控制制度
Governance Information Classification · 95% confidence The document is titled '内部控制制度' (Internal Control System) of Zhejiang Tailin Biotechnology Co., Ltd. It details the company's internal control policies, governance structure, risk management, and procedures for compliance with laws and stock exchange rules. It does not contain financial statements or financial performance data. It is a governance-related document focusing on internal control frameworks and procedures rather than a financial report or announcement. It is not a report publication announcement or a certification. Therefore, the document best fits the category of Governance Information (CGR).
2024-02-19 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.